Dr. Agarwals Health Care FY26 Earnings and Strategic Growth

Consolidated PAT increased 52.4% to Rs 168 Cr; Total Income rose 20.9% to Rs 2,125 Cr.

Reader Takeaway: Robust top-line and bottom-line growth driven by rapid network expansion; dividend payout remains paused for reinvestment.

What just happened

Dr. Agarwals Health Care Ltd released its FY26 annual report showing strong operational and financial gains. The company saw a 20.9% jump in total income to Rs 2,125 crore, while profit after tax (PAT) rose significantly to Rs 168 crore, compared to Rs 110.34 crore in FY25. The EBITDA grew by 22.2% to reach Rs 614 crore.

Why this matters

The results highlight the efficacy of the firm’s hub-and-spoke model. The company added 56 new facilities during the year, bringing its total to 288 across India and Africa. A notable achievement was the quick entry into the competitive Delhi NCR market, where it opened 7 facilities in under a year. Surgical volumes grew 14.5% to over 3.23 lakh procedures, signaling strong clinical demand.

Governance and Corporate Action

Shareholders have approved the merger of Dr. Agarwal’s Eye Hospital Limited with Dr. Agarwals Health Care Ltd. This consolidation is a key step in streamlining operations. The board has opted not to recommend a dividend for FY26, signaling that capital will be fully deployed to fund future expansion and hospital maintenance.

Risks to watch

Operating expenses increased by 17.76% in FY26, largely due to higher costs in employee benefits and stock-in-trade related to network growth. Investors should monitor whether margins remain stable as the company continues its rapid, capital-intensive expansion phase.

What to track next

Watch for the finalization of the merger integration process and the performance of new facilities in the Delhi NCR region. Clinical innovation through the 'Pinhole Pupilloplasty' technique remains a differentiator to track in the coming quarters.